Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsTOPICALGeneric

FUNGIZONE

AMPHOTERICIN B

Standard Dose
3%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview FUNGIZONE is listed in Drugs@FDA under application 050313 (NDA).
  • Marketing status: Discontinued Active ingredient AMPHOTERICIN B Form and strength OINTMENT;TOPICAL - 3% Sponsor APOTHECON Submission history Latest submission status date: 1997-06-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview FUNGIZONE is listed in Drugs@FDA under application 050313 (NDA). Marketing status: Discontinued Active ingredient AMPHOTERICIN B Form and strength OINTMENT;TOPICAL - 3% Sponsor APOTHECON Submission history Latest submission status date: 1997-06-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.